Elahere Drug Interactions
Currently displaying a list of 148 drugs known to interact with Elahere (mirvetuximab soravtansine).
- 28 major drug interactions
- 119 moderate drug interactions
- 1 minor drug interaction
Medications known to interact with Elahere
Note: Showing generic names only.
- adalimumab
- ado-trastuzumab emtansine
- amiodarone
- amprenavir
- atazanavir
- atezolizumab
- atorvastatin
- auranofin
- aurothioglucose
- avelumab
- axicabtagene ciloleucel
- cabazitaxel
- carboplatin
- carfilzomib
- cemiplimab
- ceritinib
- cerivastatin
- certolizumab
- chloramphenicol
- chloroquine
- ciltacabtagene autoleucel
- cisplatin
- clarithromycin
- cobicistat
- colchicine
- conivaptan
- cosibelimab
- crizotinib
- dapsone
- delavirdine
- deucravacitinib
- didanosine
- dinutuximab
- disulfiram
- docetaxel
- dostarlimab
- durvalumab
- elotuzumab
- elranatamab
- enfortumab vedotin
- eribulin
- etanercept
- ethambutol
- ethionamide
- etoposide
- etravirine
- idecabtagene vicleucel
- idelalisib
- indinavir
- infliximab
- interferon alfa-2a
- interferon alfa-2b
- interferon alfa-n1
- interferon alfacon-1
- iodoquinol
- ipilimumab
- isoniazid
- itraconazole
- ixabepilone
- ixazomib
- paclitaxel
- paclitaxel protein-bound
- peginterferon alfa-2a
- peginterferon alfa-2b
- pembrolizumab
- penpulimab
- pitavastatin
- polatuzumab vedotin
- pomalidomide
- ponatinib
- posaconazole
- pravastatin
- pretomanid
- talquetamab
- tarlatamab
- teclistamab
- telaprevir
- telbivudine
- telithromycin
- teniposide
- teriflunomide
- thalidomide
- tinidazole
- tisagenlecleucel
- tislelizumab
- tisotumab vedotin
- tocilizumab
- toripalimab
- trabectedin
- tremelimumab
- troleandomycin
- tucatinib
Elahere disease interactions
There are 4 disease interactions with Elahere (mirvetuximab soravtansine) which include:
Report options
More about Elahere (mirvetuximab soravtansine)
- Elahere consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (10)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Lynparza
Lynparza (olaparib) is used to treat ovarian cancer, breast cancer, pancreatic cancer, and prostate ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Zejula
Zejula (niraparib) is used to treat recurrent ovarian, fallopian tube, or peritoneal cancer ...
Zirabev
Zirabev is used for cervical cancer, colorectal cancer, fallopian tube cancer, glioblastoma ...
Mvasi
Mvasi is used for cervical cancer, colorectal cancer, fallopian tube cancer, glioblastoma ...
Avzivi
Avzivi (bevacizumab-tnjn) is a vascular endothelial growth factor (VEGF) inhibitor biosimilar to ...
Niraparib
Niraparib systemic is used for fallopian tube cancer, ovarian cancer, peritoneal cancer
Carboplatin
Carboplatin is used alone or in combination with other medications to treat ovarian cancer. Learn ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
